Final Evidence Report and Meeting Summary
New England CEPAC

PDF cover

Rheumatoid Arthritis: Final Report

ICER’s final report on targeted immune modulators for treatment of rheumatoid arthritis. The final report includes a summary of a march 2017 meeting of the New England Comparative Effectiveness Public Advisory Council (New England CEPAC).

View

View All Materials on this Topic or Go Back to View More Materials